Likun Zhuang

Prof. Likun Zhuang

Department of Infectious Diseases, Qingdao Municipal Hospital, Qingdao University, Qingdao

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MDMengzhen Dong
Mengzhen Dong
JZJie Zhang
Jie Zhang
XMXuefeng Ma
Xuefeng Ma
JTJie Tan
Jie Tan
LCLizhen Chen
Lizhen Chen
LZLikun Zhuang
Likun Zhuang
• Expressions of ACE2 and TMPRSS2 were observed in the extrapulmonary organs. • Direct infections of SARS-CoV-2 in extrapulmonary organs were observed in patients with COVID-19. • Clinical manifestation and management for extrapulmonary organ injuries in COVID-19 should be noticed. • There might be a relationship between the infection of extrapulmonary organs and positive SARS-CoV-2 test in recovered patients.

21 April 2016 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LZLikun Zhuang
Likun Zhuang
YYY T Yang
Y T Yang
XMX Ma
X Ma
BHB Han
B Han
ZWZ S Wang
Z S Wang
ZQZ Q Qu
Z Q Qu
MicroRNA (miRNA) and long non-coding RNA (lncRNA) have been demonstrated to participate in the progression of many cancers. Hepatocellular carcinoma (HCC) is one of the most common and aggressive malignant tumors worldwide, while the molecular mechanisms underlying HCC tumorigenesis are not completely clear. In this study, we showed that miR-92b was significantly upregulated in tumor tissue and plasma of HCC patients, and its expression level was highly correlated with gender and microvascular invasion. Functionally, miR-92b could promote cell proliferation and metastasis of HCC in vitro and in vivo. Mechanistic investigations suggested that Smad7, which exhibited an inverse relationship with miR-92b expression in HCC, was a direct target of miR-92b and could reverse its effects on HCC tumorigenesis. Furthermore, long non-coding RNA (lncRNA) X-inactive specific transcript (XIST) and miR-92b could directly interact with and repress each other, and XIST could inhibit HCC cell proliferation and metastasis by targeting miR-92b. Taken together, our study not only revealed for the first time the importance of XIST/miR-92b/Smad7 signaling axis in HCC progression but also suggested the potential value of miR-92b as a biomarker in the clinical diagnosis and treatment of HCC.

1 December 2016 in Anticancer Research
Verified
Journal Article
Open access
PDF file
XMXiang Ma
Xiang Ma
XWXin Wang
Xin Wang
CYChao Yang
Chao Yang
ZWZusen Wang
Zusen Wang
BHBing Han
Bing Han
LZLikun Zhuang
Likun Zhuang
Background: Long non-coding RNA differentiation antagonizing non-protein coding RNA (DANCR) is considered to be an oncogene in many cancer types. However, the role of DANCR in diagnosis and progression of hepatocellular carcinoma (HCC) is still unknown. Patients and Methods: In this study, 146 participants including healthy volunteers (HVs) and patients with chronic hepatitis B (CHB), cirrhosis and HCC were recruited. Results: Firstly, quantitative reverse transcription-PCR analysis showed that DANCR was up-regulated in tumor tissues and plasma of patients with HCC, and its expression was highly correlated with microvascular and liver capsule invasion of HCC. Receiver operating characteristic analysis showed that plasma DANCR exhibited significantly increased discriminatory power for differentiating patients with HCC from HVs and non-HCC patients compared to alpha fetoprotein, which has been used as a biomarker for HCC diagnosis. Furthermore, knockdown of DANCR repressed the β-catenin pathway and inhibited HCC cell proliferation and metastasis both in vitro and in vivo. Conclusion: This study revealed, for the first time, the importance of DANCR in clinical diagnosis and disease progression of HCC.

21 August 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CYChao Yang
Chao Yang
XMXiang Ma
Xiang Ma
GGGe Guan
Ge Guan
HLHuan Liu
Huan Liu
YYYuling Yang
Yuling Yang
LZLikun Zhuang
Likun Zhuang
MicroRNAs (miRNAs) have been reported to play important roles in tumor progression of various cancers. However, the clinical significance and biologic function of miR‐766 in hepatocellular carcinoma (HCC) remain unknown. In this study, we investigated the roles of miR‐766 in HCC progression using HCC cell lines and a xenograft mouse model. miR‐766 expression in tumor tissues and adjacent nontumorous liver tissues of patients with HCC was evaluated by quantitative RT‐PCR. Our results showed that miR‐766 promoted proliferation and metastasis of HCC cells in vitro and in vivo and that NR3C2 was a direct target of miR‐766 and involved in miR‐766–mediated proliferation and metastasis of HCC cells. We also found that miR‐766 affected the β‐catenin signaling pathway by targeting NR3C2. Furthermore, miR‐766 was significantly up‐regulated in HCC tissues and was correlated with the prognosis of patients with liver cancer. Taken together, our results show that miR‐766 affects HCC progression by modulating NR3C2 expression and is a possible new therapeutic target for patients with HCC.—Yang, C., Ma, X., Guan, G., Liu, H., Yang, Y., Niu, Q., Wu, Z., Jiang, Y., Bian, C., Zang, Y., Zhuang, L. MicroRNA‐766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma. FASEB J. 33, 1456–1467 (2019). www.fasebj.org

18 May 2017 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LZLikun Zhuang
Likun Zhuang
XWXin Wang
Xin Wang
ZWZusen Wang
Zusen Wang
XMXiang Ma
Xiang Ma
BHBing Han
Bing Han
LWLiqun Wu
Liqun Wu
Hepatocellular carcinoma (HCC) is a malignant tumor and threatens human life worldwide, whereas the etiology and pathogenesis of HCC have not been fully determined. In the past few years, many microRNAs (miRNAs) have been proved to have important roles in tumorigenesis of HCC. In this study, we found that miR-23b was significantly upregulated in tumor tissues of HCC patients. Functional tests showed that miR-23b could promote HCC cell proliferation and metastasis in vitro and in vivo. Then, mechanistic investigations suggested that ST7L was a direct target of miR-23b and involved in the promotion effects of miR-23b on HCC tumorigenesis and metastasis. Furthermore, our study indicated that ST7L could interact with the carboxyl terminal region of AKT and suppress AKT/GSK3β/β-catenin pathway in HCC cells. In conclusion, our study revealed important roles of miR-23b and ST7L in progression of HCC.

5 November 2021 in Science Advances
Verified
Journal Article
Open access
JZJie Zhang
Jie Zhang
JTJie Tan
Jie Tan
MWMengke Wang
Mengke Wang
YWYifen Wang
Yifen Wang
MDMengzhen Dong
Mengzhen Dong
LZLikun Zhuang
Likun Zhuang
DRAM-mediated mechanism participates in lipid-induced exosome secretion from hepatic cells in NAFLD.